Nithya Desikan, Chief Commercial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 25,000 shares at $30.00 ($750K) on 2020-08-31, disclosed to the SEC on 2020-09-01.
Open-market sale of $750k RYTM by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.